Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Amphetamine-Related Disorders

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Amphetamine-Related Disorders in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, ES1
Wang, JQ1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Amphetamine-Related Disorders

ArticleYear
CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons.
    Neuroreport, 2002, Jun-12, Volume: 13, Issue:8

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amphetamine; Amphetamine-Related Disorders; Animals;

2002